# miRNA Panel for PCa Diagnosis

> **NCT07755592** · — · RECRUITING · sponsor: **RenJi Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Prostate Cancer (Diagnosis)

## Interventions

- **DIAGNOSTIC_TEST:** Serum microRNA panel detection for prostate lesion differentiation

## Key facts

- **NCT ID:** NCT07755592
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-13
- **Primary completion:** 2027-10-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07755592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07755592, "miRNA Panel for PCa Diagnosis". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07755592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*